Insider Stock Trading History of Antinori Paul Michael


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Antinori Paul Michael since year 2005. The trader's CIK number is 1318459. At the time of this reporting, Antinori Paul Michael is the SVP and General Coun of Medicines Co /de . (stock ticker symbol MDCO). See this page for all insider trading activities at Medicines Co /de .


Stock purchases, sales, and option exercises reported by insider Antinori Paul Michael since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-01-21 MDCO Medicines Co /de Sale 37,883 37.99 1,439,213
2014-01-21 MDCO Medicines Co /de Option Ex 37,500 13.19 494,737
2013-12-12 MDCO Medicines Co /de Sale 10,000 37.01 370,110
2013-12-13 MDCO Medicines Co /de Sale 9,600 36.91 354,335
2013-09-27 MDCO Medicines Co /de Sale 894 33.16 29,645
2013-09-13 MDCO Medicines Co /de Sale 73,500 34.50 2,535,750
2013-09-13 MDCO Medicines Co /de Option Ex 73,500 28.31 2,080,785
2013-07-08 MDCO Medicines Co /de Option Ex 36,000 23.77 855,720
2013-07-08 MDCO Medicines Co /de Sale 36,000 33.00 1,188,000
2013-06-11 MDCO Medicines Co /de Option Ex 109,973 18.26 2,008,106
2013-06-11 MDCO Medicines Co /de Sale 109,973 33.29 3,660,671
2013-05-09 MDCO Medicines Co /de Sale 35,000 34.90 1,221,500
2013-05-09 MDCO Medicines Co /de Option Ex 35,000 17.66 617,925
2013-02-25 MDCO Medicines Co /de Sale 1,067 31.22 33,311
2013-02-20 MDCO Medicines Co /de Sale 1,027 32.42 33,295
2013-02-20 MDCO Medicines Co /de Option Ex 6,500 18.27 118,755
2013-02-19 MDCO Medicines Co /de Sale 569 31.81 18,099
2013-02-20 MDCO Medicines Co /de Sale 6,500 32.50 211,250
2013-02-14 MDCO Medicines Co /de Sale 6,000 30.90 185,400
2013-02-14 MDCO Medicines Co /de Option Ex 6,000 27.81 166,860
2013-01-15 MDCO Medicines Co /de Option Ex 6,000 18.27 109,620
2013-01-15 MDCO Medicines Co /de Sale 9,781 29.70 290,495
2013-01-08 MDCO Medicines Co /de Sale 3,500 27.90 97,650
2012-09-17 MDCO Medicines Co /de Sale 559 26.04 14,556
2012-08-21 MDCO Medicines Co /de Sale 3,000 25.25 75,750
2012-08-14 MDCO Medicines Co /de Sale 2,158 25.25 54,489
2012-08-15 MDCO Medicines Co /de Sale 3,504 25.38 88,914
2012-08-10 MDCO Medicines Co /de Sale 4,500 25.00 112,500
2012-08-10 MDCO Medicines Co /de Option Ex 4,500 15.50 69,750
2012-04-16 MDCO Medicines Co /de Option Ex 18,750 9.13 171,187
2012-02-21 MDCO Medicines Co /de Sale 1,579 20.94 33,064
2012-02-14 MDCO Medicines Co /de Sale 500 20.89 10,445
2012-02-03 MDCO Medicines Co /de Option Ex 5,000 9.13 45,650
2012-02-03 MDCO Medicines Co /de Sale 5,000 22.00 110,000
2011-12-13 MDCO Medicines Co /de Sale 485 19.46 9,438
2011-02-18 MDCO Medicines Co /de Sale 500 17.45 8,725
2011-02-22 MDCO Medicines Co /de Sale 1,462 17.28 25,263
2007-08-03 MDCO Medicines Co /de Buy 1,000 15.90 15,900
2006-10-26 MDCO Medicines Co /de Option Ex 5,000 9.13 45,650
2006-10-26 MDCO Medicines Co /de Sale 5,000 25.00 125,000
2006-10-23 MDCO Medicines Co /de Sale 5,000 24.00 120,000
2006-10-23 MDCO Medicines Co /de Option Ex 5,000 9.13 45,650
2006-08-21 MDCO Medicines Co /de Option Ex 5,000 9.13 45,650
2006-08-21 MDCO Medicines Co /de Sale 5,000 22.00 110,000
2006-02-27 MDCO Medicines Co /de Option Ex 5,000 9.13 45,650
2006-02-27 MDCO Medicines Co /de Sale 5,964 20.00 119,280

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Antinori Paul Michael (SVP and General Coun of Medicines Co /de at the time of this reporting) see the Securities and Exchange Commission (SEC) website.